Launching an orphan drug without an approved treatment? Need to estimate a forecast without really knowing thetrue prevalence? Does the lack of an ICD-10 code for the disease make all this even more complicated? In this webinar, IPM.ai and X4 Pharmaceuticals discuss cutting-edge methodologies via analogies and case studies that address the above conundrums common to the industry
Learn how IPM.ai transforms real world data into real world insights that uncover the ideal patient and their healthcare ecosystem so pharmaceutical companies can accelerate the successful research, development and commercialization of life-savings therapies.